A review on the dosimetrical and radiobiological prediction of radiation-induced hypothyroidism in radiation therapy of head-and-neck cancer, breast cancer, and Hodgkin’s lymphoma survivors

[1] Mirinezhad SK, Somi MH, Jangjoo AG, et al. Survival rate and prognostic factors of esophageal cancer in East Azerbaijan province, North-west of Iran. Asian Pac J Cancer Prev. 2012;13(7):3451-3454.10.7314/APJCP.2012.13.7.3451Search in Google Scholar

[2] Mirinezhad SK, Somi MH, Seyednezhad F, et al: Influence of chemoradio therapeutic strategies and factors on the five yearssurvival of patients with esophageal cancer. Journal of Isfahan Medical School 2014;32(291):982-990.Search in Google Scholar

[3] Mohammadzadeh M, Faramarzi E, Mahdavi R, et al. Effect of conjugated linoleic acid supplementation on inflammatory factors and matrix metalloproteinase enzymes in rectal cancer patients undergoing chemoradiotherapy. Integr Cancer Ther. 2013;12(6):496-502.10.1177/1534735413485417Search in Google Scholar

[4] Mesbahi A, Dadgar H, Ghareh-Aghaji N, Mohammadzadeh M. A Monte Carlo approach to lung dose calculation in small fields used in intensity modulated radiation therapy and stereotactic body radiation therapy. J Cancer Res Ther. 2014;10(4):896-902.10.4103/0973-1482.137989Search in Google Scholar

[5] Mesbahi A, Dadgar H. Dose calculations accuracy of TiGRT treatment planning system for small IMRT beamlets in heterogeneous lung phantom. Int J Radiat Res. 2015;13(4):345-354.Search in Google Scholar

[6] Mesbahi A, Akcay D, Tekcan IV, Alikus ZA. The impact of residual geometric inaccuracies on normal organ doses in image guided-radiation therapy of prostate cancer using on-board kilovoltage Cone-Beam computed tomography. Iran J Med Phys. 2017;14(2):104-113.Search in Google Scholar

[7] Mohammadzadeh M, Mesbahi A. MC estimation of out-of-field organ doses from scattered photons, photoneutrons, and capture gamma rays in prostate radiation therapy. Nuclear Technology and Radiation Protection. 2010;25:78-84.10.2298/NTRP1002078MSearch in Google Scholar

[8] Boyle P, Levin B: World Cancer Report 2008. International Agency for Research on Cancer.Search in Google Scholar

[9] Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.10.3322/canjclin.57.1.43Search in Google Scholar

[10] NCCN Clinical Practice Guidelines in Oncology. Breast cancer. ver.2. 2016. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf: 2017.Search in Google Scholar

[11] Wang SA, Rahemtullah A, Faquin WC, et al. Hodgkin’s lymphoma of the thyroid: a clinicopathologic study of five cases and review of the literature. Mod Pathol. 2005;18(12):1577-1584.10.1038/modpathol.3800501Search in Google Scholar

[12] Alterio D, Jereczek-Fossa BA, Franchi B, et al. Thyroid disorders in patients treated with radiotherapy for head-and-neck cancer: a retrospective analysis of seventy-three patients. Int J Radiat Oncol Biol Phys. 2007;67(1):144-150.10.1016/j.ijrobp.2006.08.051Search in Google Scholar

[13] Bethge W, Guggenberger D, Bamberg M, et al. Thyroid toxicity of treatment for Hodgkin’s disease. Ann Hematol. 2000;79(3):114-118.10.1007/s002770050565Search in Google Scholar

[14] Reinertsen KV, Cvancarova M, Wist E, et al. Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample. Int J Radiat Oncol Biol Phys. 2009;75(3):764-770.10.1016/j.ijrobp.2008.11.037Search in Google Scholar

[15] Hancock SL, McDougall IR, Constine LS. Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys. 1995;31(5):1165-1170.10.1016/0360-3016(95)00019-USearch in Google Scholar

[16] Jereczek-Fossa BA, Alterio D, Jassem J, et al. Radiotherapy-induced thyroid disorders. Cancer Treat Rev. 2004;30(4):369-384.10.1016/j.ctrv.2003.12.003Search in Google Scholar

[17] Bhandare N, Kennedy L, Malyapa RS, et al. Primary and central hypothyroidism after radiotherapy for head-and-neck tumors. Int J Radiat Oncol Biol Phys. 2007;68(4):1131-1139.10.1016/j.ijrobp.2007.01.029Search in Google Scholar

[18] Kuten A, Lubochitski R, Fishman G, et al. Postradiotherapy hypothyroidism: radiation dose response and chemotherapeutic radiosensitization at less than 40 Gy. J Surg Oncol. 1996;61(4):281-283.10.1002/(SICI)1096-9098(199604)61:4<281::AID-JSO10>3.0.CO;2-9Search in Google Scholar

[19] Boomsma MJ, Bijl HP, Langendijk JA. Radiation-induced hypothyroidism in head and neck cancer patients: a systematic review. Radiother Oncol. 2011;99(1):1-5.10.1016/j.radonc.2011.03.002Search in Google Scholar

[20] Mercado G, Adelstein DJ, Saxton JP, et al. Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. Cancer. 2001;92(11):2892-2897.10.1002/1097-0142(20011201)92:11<2892::AID-CNCR10134>3.0.CO;2-TSearch in Google Scholar

[21] Tell R, Lundell G, Nilsson B, et al. Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004;60(2):395-400.10.1016/j.ijrobp.2004.03.020Search in Google Scholar

[22] Akyurek S, Babaoglu I, Kose K, Gokce SC. Thyroid Dysfunction Following Supraclavicular Irradiation in the Management of Carcinoma of the Breast. In J Hemat Oncol. 2014;24(2):139-144.10.4999/uhod.14234Search in Google Scholar

[23] Kikawa Y, Kosaka Y, Hashimoto K, et al. Prevalence of hypothyroidism among patients with breast cancer treated with radiation to the supraclavicular field: a single-centre survey. ESMO Open 2017;2:e000161.10.1136/esmoopen-2017-000161Search in Google Scholar

[24] Smith GL, Smith BD, Giordano SH, et al. Risk of hypothyroidism in older breast cancer patients treated with radiation. Cancer. 2008;112(6):1371-1379.10.1002/cncr.23307Search in Google Scholar

[25] Fuks Z, Glatstein E, Marsa GW, et al. Long-term effects on external radiation on the pituitary and thyroid glands. Cancer. 1976;37(2Suppl):1152-1161.10.1002/1097-0142(197602)37:2+<1152::AID-CNCR2820370826>3.0.CO;2-TSearch in Google Scholar

[26] Bakhshandeh M, Hashemi B, Mahdavi SR, et al. Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck radiation therapy. Int J Radiat Oncol Biol Phys. 2013;85(2):514-521.10.1016/j.ijrobp.2012.03.034Search in Google Scholar

[27] V.D’Avino, Conson M, Palma G, et al. Normal Tissue Complication Probability Models for Radiation-Induced Hypothyroidism in Hodgkin Lymphoma Survivors. Int J Radiat Oncol Biol Phys. 2016;96(2):E638.10.1016/j.ijrobp.2016.06.2227Search in Google Scholar

[28] Goldberg RC, Chaikoff IL,Lindsay S, Feller DD. Histopathological changes induced in the normal thyroid and other tissues of the rat by internal radiation with various doses of radioactive iodine. Endocrinology. 1950;46(1):72-90.10.1210/endo-46-1-72Search in Google Scholar

[29] Nishiyama K, Tanaka E, Tarui Y, et al. A prospective analysis of subacute thyroid dysfunction after neck irradiation. Int J Radiat Oncol Biol Phys. 1996;34(2):439-444.10.1016/0360-3016(95)02079-9Search in Google Scholar

[30] Bakhshandeh M, Hashemi B, Mahdavi SR, et al. Evaluation of thyroid disorders during head-and-neck radiotherapy by using functional analysis and ultrasonography. Int J Radiat Oncol Biol Phys. 2012;83(1):198-203.10.1016/j.ijrobp.2011.05.064Search in Google Scholar

[31] Carr RF, LiVolsi VA. Morphologic changes in the thyroid after irradiation for Hodgkin’s and non-Hodgkin’s lymphoma. Cancer. 1989;64(4):825-829.10.1002/1097-0142(19890815)64:4<825::AID-CNCR2820640411>3.0.CO;2-ESearch in Google Scholar

[32] Lo Galbo AM, Kuik DJ, Lips P, et al. A prospective longitudinal study on endocrine dysfunction following treatment of laryngeal or hypopharyngeal carcinoma. Oral Oncol. 2013;49(9):950-955.10.1016/j.oraloncology.2013.03.450Search in Google Scholar

[33] Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin’s disease. N Engl J Med. 1991;325(9):599-605.10.1056/NEJM199108293250902Search in Google Scholar

[34] Norris AA, Amdur RJ, Morris CG, Mendenhall WM. Hypothyroidism when the thyroid is included only in the low neck field during head and neck radiotherapy. Am J Clin Oncol. 2006;29(5):442-445.10.1097/01.coc.0000217831.23820.85Search in Google Scholar

[35] Brix TH, Kyvik KO, Hegedus L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab. 2000;85(2):536-539.10.1210/jc.85.2.536Search in Google Scholar

[36] Brix TH, Hansen PS, Kyvik KO, Hegedus L. Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case-control study. Arch Intern Med. 2000;160(5):661-666.10.1001/archinte.160.5.661Search in Google Scholar

[37] Brix TH, Hegedus L. Twin studies as a model for exploring the aetiology of autoimmune thyroid disease. Clin Endocrinol (Oxf). 2012;76(4):457-464.10.1111/j.1365-2265.2011.04318.xSearch in Google Scholar

[38] Laurberg P, Cerqueira C, Ovesen L, et al. Iodine intake as a determinant of thyroid disorders in populations. Best Pract Res Clin Endocrinol Metab. 2010;24(1):13-27.10.1016/j.beem.2009.08.013Search in Google Scholar

[39] Kumpulainen EJ, Hirvikoski PP, Virtaniemi JA, et al. Hypothyroidism after radiotherapy for laryngeal cancer. Radiother Oncol. 2000;57(1):97-101.10.1016/S0167-8140(00)00276-0Search in Google Scholar

[40] Bonato C, Severino RF, Elnecave RH. Reduced thyroid volume and hypothyroidism in survivors of childhood cancer treated with radiotherapy. J Pediatr Endocrinol Metab. 2008;21(10):943-949.10.1515/JPEM.2008.21.10.943Search in Google Scholar

[41] Garcia-Serra A, Amdur RJ, Morris CG, et al. Thyroid function should be monitored following radiotherapy to the low neck. Am J Clin Oncol. 2005;28(3):255-258.10.1097/01.coc.0000145985.64640.acSearch in Google Scholar

[42] Grande C. Hypothyroidism following radiotherapy for head and neck cancer: multivariate analysis of risk factors. Radiother Oncol. 1992;25(1):31-36.10.1016/0167-8140(92)90192-WSearch in Google Scholar

[43] Sklar C, Whitton J, Mertens A, et al. Abnormalities of the thyroid in survivors of Hodgkin’s disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab. 2000;85(9):3227-3232.10.1210/jc.85.9.3227Search in Google Scholar

[44] Akgun Z, Atasoy BM, Ozen Z, et al. V30 as a predictor for radiation-induced hypothyroidism: a dosimetric analysis in patients who received radiotherapy to the neck. Radiat Oncol. 2014;9:104.10.1186/1748-717X-9-104402983124885512Search in Google Scholar

[45] Cella L, Conson M, Caterino M, et al. Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys. 2012;82(5):1802-1808.10.1016/j.ijrobp.2010.09.05421514076Search in Google Scholar

[46] Chyan A, Chen J, Shugard E, et al. Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy. Radiat Oncol. 2014;9:269.10.1186/s13014-014-0269-4Search in Google Scholar

[47] Fujiwara M, Kamikonya N, Odawara S, et al. The threshold of hypothyroidism after radiation therapy for head and neck cancer: a retrospective analysis of 116 cases. J Radiat Res. 2015;56(3):577-582.10.1093/jrr/rrv006Search in Google Scholar

[48] Sachdev S, Refaat T, Bacchus ID, et al. Thyroid V50 Highly Predictive of Hypothyroidism in Head-and-Neck Cancer Patients Treated With Intensity-modulated Radiotherapy (IMRT). Am J Clin Oncol. 2017;40(4):413-417.10.1097/COC.0000000000000165Search in Google Scholar

[49] Zhai RP, Kong FF, Du CR, et al. Radiation-induced hypothyroidism after IMRT for nasopharyngeal carcinoma: Clinical and dosimetric predictors in a prospective cohort study. Oral Oncol. 2017;68:44-49.10.1016/j.oraloncology.2017.03.005Search in Google Scholar

[50] Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76:S10-S19.10.1016/j.ijrobp.2009.07.1754Search in Google Scholar

[51] Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21(1):109-122.10.1016/0360-3016(91)90171-YSearch in Google Scholar

[52] Boomsma MJ, Bijl HP, Christianen ME, et al. A prospective cohort study on radiation-induced hypothyroidism: development of an NTCP model. Int J Radiat Oncol Biol Phys. 2012;84:e351-e356.10.1016/j.ijrobp.2012.05.020Search in Google Scholar

[53] Kim ES, Yeo SG. Volumetric modulated arc radiotherapy sparing the thyroid gland for early-stage glottic cancer: A dosimetrical analysis. Oncol Lett. 2014;7(6):1987-1991.10.3892/ol.2014.2039Search in Google Scholar

[54] Tsougos I, Mavroidis P, Rajala J, et al. Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy. Phys Med Biol. 2005;50(15):3535-3554.10.1088/0031-9155/50/15/004Search in Google Scholar

[55] Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 1991;21(1):123-135.10.1016/0360-3016(91)90172-ZSearch in Google Scholar

[56] Emami B. Tolerance of Normal Tissue to Therapeutic Radiation. Rep Radiother Oncol. 2013;1(1):123-127.Search in Google Scholar

[57] Cella L, Liuzzi R, Conson M, et al. Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis. Radiation Oncology. 2012;7:224.10.1186/1748-717X-7-224Search in Google Scholar

[58] Ronjom MF, Brink C, Bentzen SM, et al. Hypothyroidism after primary radiotherapy for head and neck squamous cell carcinoma: normal tissue complication probability modeling with latent time correction. Radiother Oncol. 2013;109(2):317-322.10.1016/j.radonc.2013.06.029Search in Google Scholar

[59] Ronjom MF, Brink C, Lorenzen EL, et al. Variation of normal tissue complication probability (NTCP) estimates of radiation-induced hypothyroidism in relation to changes in delineation of the thyroid gland. Acta Oncol. 2015;54(8):1188-1194.10.3109/0284186X.2014.1001034Search in Google Scholar

[60] Johansen S, Reinertsen KV, Knutstad K, et al. Dose distribution in the thyroid gland following radiation therapy of breast cancer-a retrospective study. Radiat Oncol. 2011;6:68.10.1186/1748-717X-6-68Search in Google Scholar

[61] Tunio MA, Al AM, Bayoumi Y, et al. Is thyroid gland an organ at risk in breast cancer patients treated with locoregional radiotherapy? Results of a pilot study. J Cancer Res Ther. 2015;11(4):684-689.10.4103/0973-1482.167613Search in Google Scholar

[62] Sommat K, Ong WS, Hussain A, et al. Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2017;98(3):574-580.10.1016/j.ijrobp.2017.03.007Search in Google Scholar

[63] Kim MY, Yu T, Wu HG. Dose-volumetric parameters for predicting hypothyroidism after radiotherapy for head and neck cancer. Jpn J Clin Oncol. 2014;44(3):331-337.10.1093/jjco/hyt235Search in Google Scholar

[64] Jackson A, Kutcher GJ, Yorke ED. Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation. Med Phys. 1993;20(3):613-625.10.1118/1.597056Search in Google Scholar

[65] Niemierko A, Goitein M. Modeling of normal tissue response to radiation: the critical volume model. Int J Radiat Oncol Biol Phys. 1993;25(1):135-145.10.1016/0360-3016(93)90156-PSearch in Google Scholar

[66] Yorke ED, Kutcher GJ, Jackson A, Ling CC. Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation. Radiother Oncol. 1993;26(3):226-237.10.1016/0167-8140(93)90264-9Search in Google Scholar

[67] Lo Galbo AM, de BR, Kuik DJ, et al. The prevalence of hypothyroidism after treatment for laryngeal and hypopharyngeal carcinomas: are autoantibodies of influence? Acta Otolaryngol. 2007;127(3):312-317.10.1080/0001648060081809617364370Search in Google Scholar

[68] Vogelius IR, Bentzen SM, Maraldo MV, et al. Risk factors for radiation-induced hypothyroidism: a literature-based meta-analysis. Cancer. 2011;117(23):5250-5260.10.1002/cncr.2618621567385Search in Google Scholar

[69] Diaz R, Jaboin JJ, Morales-Paliza M, et al. Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010;77(2):468-476.10.1016/j.ijrobp.2009.05.01819577867Search in Google Scholar

[70] Wu YH, Wang HM, Chen HH, et al. Hypothyroidism after radiotherapy for nasopharyngeal cancer patients. Int J Radiat Oncol Biol Phys. 2010;76(4):1133-1139.10.1016/j.ijrobp.2009.03.01119596170Search in Google Scholar

[71] Lin Z, Wu VW, Lin J, et al. A longitudinal study on the radiation-induced thyroid gland changes after external beam radiotherapy of nasopharyngeal carcinoma. Thyroid. 2011;21(1):19-23.10.1089/thy.2010.022921054241Search in Google Scholar

[72] Srikantia N, Rishi KS, Janaki MG, et al. How common is hypothyroidism after external radiotherapy to neck in head and neck cancer patients? Indian J Med Paediatr Oncol. 2011;32(3):143-148.10.4103/0971-5851.92813334272022557780Search in Google Scholar

[73] Siala W, Mnejja W, Abid M, et al. Thyroid toxicity after radiotherapy of nasopharyngeal carcinoma. Annales d’Endocrinologie. 2011;72(1):19-23.10.1016/j.ando.2010.06.00520727518Search in Google Scholar

[74] Lin Z, Wang X, Xie W, et al. Evaluation of clinical hypothyroidism risk due to irradiation of thyroid and pituitary glands in radiotherapy of nasopharyngeal cancer patients. J Med Imaging Radiat Oncol. 2013;57(6):713-718.10.1111/1754-9485.1207424283561Search in Google Scholar

[75] Lin Z, Chen L, Fang Y, et al. Longitudinal study on the correlations of thyroid antibody and thyroid hormone levels after radiotherapy in patients with nasopha-ryngeal carcinoma with radiation-induced hypothyroidism. Head Neck. 2014;36(2):171-175.10.1002/hed.2328523559564Search in Google Scholar

[76] Murthy V, Narang K, Ghosh-Laskar S, at al. Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: Prospective data from 2 randomized con-trolled trials. Head Neck. 2014;36(11):1573-1580.10.1002/hed.2348223996654Search in Google Scholar

[77] Lauro C, Macy ME, Zeitler P, et al. The relationship between thyroid dose and diagnosis of primary hypothyroidism in pediatric brain tumor patients receiving craniospinal irradiation. J Pediatr Endocrinol Metab. 2014;27(3-4):299-303.10.1515/jpem-2013-0063417257624057590Search in Google Scholar

[78] Bernat L, Hrusak D. Hypothyroidism after radiotherapy of head and neck cancer. J Craniomaxillofac Surg. 2014;42(4):356-361.10.1016/j.jcms.2013.09.00924210455Search in Google Scholar

[79] Lee V, Chan SY, Choi CW, et al. Dosimetric Predictors of Hypothyroidism After Radical Intensity-modulated Radiation Therapy for Non-metastatic Nasopharyngeal Carcinoma. Clin Oncol. 2016;28(8):e52-e60.10.1016/j.clon.2016.05.00427235379Search in Google Scholar